ATE432068T1 - Cetirizin und pseudoephedrin enthaltende tablette - Google Patents

Cetirizin und pseudoephedrin enthaltende tablette

Info

Publication number
ATE432068T1
ATE432068T1 AT02743173T AT02743173T ATE432068T1 AT E432068 T1 ATE432068 T1 AT E432068T1 AT 02743173 T AT02743173 T AT 02743173T AT 02743173 T AT02743173 T AT 02743173T AT E432068 T1 ATE432068 T1 AT E432068T1
Authority
AT
Austria
Prior art keywords
pseudoephedrine
tablet containing
containing cetirizine
cetirizine
tablet
Prior art date
Application number
AT02743173T
Other languages
English (en)
Inventor
Domenico Fanara
Anthony Guichaux
Monique Berwaer
Michel Deleers
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Application granted granted Critical
Publication of ATE432068T1 publication Critical patent/ATE432068T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
AT02743173T 2001-06-28 2002-06-10 Cetirizin und pseudoephedrin enthaltende tablette ATE432068T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30125001P 2001-06-28 2001-06-28
EP01115807 2001-06-28
PCT/EP2002/006342 WO2003002098A1 (en) 2001-06-28 2002-06-10 Tablet comprising cetirizine and pseudoephedrine

Publications (1)

Publication Number Publication Date
ATE432068T1 true ATE432068T1 (de) 2009-06-15

Family

ID=56290291

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02743173T ATE432068T1 (de) 2001-06-28 2002-06-10 Cetirizin und pseudoephedrin enthaltende tablette

Country Status (22)

Country Link
EP (1) EP1404304B1 (de)
JP (1) JP4041460B2 (de)
KR (1) KR100926410B1 (de)
CN (1) CN100490809C (de)
AT (1) ATE432068T1 (de)
AU (1) AU2002345024B2 (de)
BR (1) BR0210650A (de)
CA (1) CA2451519C (de)
CZ (1) CZ20033454A3 (de)
DK (1) DK1404304T3 (de)
EE (1) EE05357B1 (de)
ES (1) ES2324769T3 (de)
HU (1) HU229803B1 (de)
MX (1) MXPA03010430A (de)
NZ (1) NZ530289A (de)
PL (1) PL206069B1 (de)
PT (1) PT1404304E (de)
RO (1) RO122476B1 (de)
RU (1) RU2286784C2 (de)
SI (1) SI1404304T1 (de)
SK (1) SK287645B6 (de)
WO (1) WO2003002098A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159287A0 (en) * 2001-06-28 2004-06-01 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
WO2007141743A2 (en) * 2006-06-06 2007-12-13 Ranbaxy Laboratories Limited A tablet dosage form comprising cetirizine and pseudoephedrine
PL2099442T3 (pl) 2006-12-26 2015-04-30 Pharmacyclics Inc Sposób stosowania inhibitorów deacetylazy histonów i monitoringu biomarkerów w terapii skojarzonej
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
KR101193495B1 (ko) 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
US9044479B2 (en) 2010-06-16 2015-06-02 Bruce Chandler May Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation
CN102302497A (zh) * 2011-05-18 2012-01-04 天圣制药集团股份有限公司 一种治疗过敏性鼻炎的制剂及其制备方法
KR20130009553A (ko) 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
AU2011376953B2 (en) 2011-09-13 2017-08-24 Pharmacyclics Llc Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
KR101372324B1 (ko) * 2012-02-09 2014-03-13 동국대학교 경주캠퍼스 산학협력단 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물
ES2660494T3 (es) 2013-03-13 2018-03-22 14779507 Uso de levocetirizina y montelukast en el tratamiento de una lesión traumática
AU2014249534B2 (en) 2013-03-13 2018-08-30 IRR, Inc. Use of levocetirizine and montelukast in the treatment of vasculitis
ES2745041T3 (es) 2013-03-13 2020-02-27 Inflammatory Response Res Inc Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunitarios
EP3193875B1 (de) 2014-09-15 2022-02-16 Inflammatory Response Research, Inc. Levocetirizin und montelukast in der behandlung von entzündungsvermittelten störungen
WO2016140630A1 (en) 2015-03-05 2016-09-09 PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. An effervescent composition comprising levocetirizine and pseudoephedrine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811374A1 (de) * 1996-05-29 1997-12-10 Pfizer Inc. Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine

Also Published As

Publication number Publication date
BR0210650A (pt) 2004-10-05
WO2003002098A1 (en) 2003-01-09
PL366800A1 (en) 2005-02-07
PT1404304E (pt) 2009-06-26
EP1404304A1 (de) 2004-04-07
EE05357B1 (et) 2010-12-15
MXPA03010430A (es) 2004-12-06
KR20040007756A (ko) 2004-01-24
KR100926410B1 (ko) 2009-11-12
CA2451519A1 (en) 2003-01-09
JP2004536829A (ja) 2004-12-09
NZ530289A (en) 2004-11-26
CA2451519C (en) 2007-11-06
RO122476B1 (ro) 2009-07-30
PL206069B1 (pl) 2010-06-30
JP4041460B2 (ja) 2008-01-30
CN100490809C (zh) 2009-05-27
SK15502003A3 (sk) 2004-05-04
SI1404304T1 (sl) 2009-10-31
DK1404304T3 (da) 2009-07-13
HUP0400386A3 (en) 2006-02-28
SK287645B6 (sk) 2011-05-06
CZ20033454A3 (cs) 2004-08-18
RU2286784C2 (ru) 2006-11-10
HUP0400386A2 (hu) 2004-08-30
RU2004101231A (ru) 2005-04-20
HU229803B1 (en) 2014-07-28
AU2002345024B2 (en) 2006-09-07
EE200400005A (et) 2004-02-16
ES2324769T3 (es) 2009-08-14
CN1520285A (zh) 2004-08-11
EP1404304B1 (de) 2009-05-27

Similar Documents

Publication Publication Date Title
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
NO20051966L (no) Nye pyrimidinamidderivater og anvendelse derav
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
ATE396202T1 (de) Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
DK1781277T3 (da) Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
ATE302600T1 (de) Arzneimittel auf basis von tramadol
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
DE60225686D1 (de) Paracetamol enthaltende tablette
ATE524186T1 (de) Pharmazeutische kombinationen bestehend aus meloxicam, tramadol und paracetamol
DE50109572D1 (de) Parental applizierbare darreichungsformen enthaltend eine suspension des salzes aus tramadol und diclofenac
ATE402703T1 (de) Tablette enthaltend efletirizin und pseudoephedrin
RS50523B (sr) Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze
SE0004827D0 (sv) Therapeutic compounds
ATE270551T1 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
DE50304524D1 (de) Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole
HU0105291D0 (en) Pharmaceutical compositions for the treatment of indigestion and related diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404304

Country of ref document: EP